Fulcrum Therapeutics Cash from Financing (TTM) Trends

Fulcrum Therapeutics Inc (FULC)

7.14 -0.14 (-1.92%) USD | NASDAQ | Apr 25, 16:00

7.14 0.00 (0.00%) After-Hours: 16:44

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	118.12M
September 30, 2023	118.05M
June 30, 2023	199.00M
March 31, 2023	201.67M
December 31, 2022	84.32M
September 30, 2022	85.00M
June 30, 2022	141.95M
March 31, 2022	139.35M
December 31, 2021	186.51M
September 30, 2021	191.87M
June 30, 2021	53.88M

Date	Value
March 31, 2021	118.36M
December 31, 2020	71.13M
September 30, 2020	64.60M
June 30, 2020	129.88M
March 31, 2020	64.66M
December 31, 2019	64.34M
September 30, 2019	64.53M
June 30, 2019	79.16M
March 31, 2019	92.34M
December 31, 2018	105.02M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

53.88M

Minimum

Jun 2021

201.67M

Maximum

Mar 2023

114.55M

Average

118.05M

Median

Sep 2023

Cash from Financing (TTM) Benchmarks